TRADES
Latest Trades
83
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 8 Sep 2021 Buy FATE FATE THERAPEUTICS INC 55,010 0.0500
ARKK 8 Sep 2021 Buy FATE FATE THERAPEUTICS INC 74,729 0.0200
ARKK 7 Sep 2021 Buy FATE FATE THERAPEUTICS INC 48,314 0.0200
ARKG 3 Sep 2021 Buy FATE FATE THERAPEUTICS INC 74,850 0.0600
ARKK 3 Sep 2021 Buy FATE FATE THERAPEUTICS INC 162,959 0.0500
ARKK 2 Sep 2021 Buy FATE FATE THERAPEUTICS INC 148,263 0.0500
ARKK 1 Sep 2021 Buy FATE FATE THERAPEUTICS INC 1,075 0.0004
ARKG 31 Aug 2021 Buy FATE FATE THERAPEUTICS INC 62,266 0.0534
ARKK 30 Aug 2021 Buy FATE FATE THERAPEUTICS INC 89,825 0.0294
ARKG 27 Aug 2021 Buy FATE FATE THERAPEUTICS INC 57,841 0.0509
ARKK 27 Aug 2021 Buy FATE FATE THERAPEUTICS INC 114,617 0.0378
ARKK 26 Aug 2021 Buy FATE FATE THERAPEUTICS INC 60,075 0.0193
ARKK 25 Aug 2021 Buy FATE FATE THERAPEUTICS INC 1,000 0.0003
ARKG 24 Aug 2021 Buy FATE FATE THERAPEUTICS INC 171,840 0.1497
ARKK 24 Aug 2021 Buy FATE FATE THERAPEUTICS INC 357,508 0.1171
ARKG 23 Aug 2021 Buy FATE FATE THERAPEUTICS INC 55,219 0.0489
ARKK 23 Aug 2021 Buy FATE FATE THERAPEUTICS INC 151,829 0.0502
ARKG 20 Aug 2021 Buy FATE FATE THERAPEUTICS INC 105,042 0.0949
ARKK 20 Aug 2021 Buy FATE FATE THERAPEUTICS INC 292,854 0.0982
ARKK 18 Aug 2021 Buy FATE FATE THERAPEUTICS INC 102 0.0000
ARKK 17 Aug 2021 Buy FATE FATE THERAPEUTICS INC 32,533 0.0125
ARKK 16 Aug 2021 Buy FATE FATE THERAPEUTICS INC 65,163 0.0244
ARKK 11 Aug 2021 Buy FATE FATE THERAPEUTICS INC 159,503 0.0630
ARKK 10 Aug 2021 Buy FATE FATE THERAPEUTICS INC 21,200 0.0082
ARKG 4 Aug 2021 Buy FATE FATE THERAPEUTICS INC 82,289 0.0798
ARKK 4 Aug 2021 Buy FATE FATE THERAPEUTICS INC 30,751 0.0114
ARKG 3 Aug 2021 Buy FATE FATE THERAPEUTICS INC 55,163 0.0548
ARKK 3 Aug 2021 Buy FATE FATE THERAPEUTICS INC 186,114 0.0678
ARKG 2 Aug 2021 Buy FATE FATE THERAPEUTICS INC 27,556 0.0273
ARKG 30 Jul 2021 Buy FATE FATE THERAPEUTICS INC 77,889 0.0754
ARKG 29 Jul 2021 Buy FATE FATE THERAPEUTICS INC 69,851 0.0689
ARKG 28 Jul 2021 Buy FATE FATE THERAPEUTICS INC 8,774 0.0084
ARKG 27 Jul 2021 Buy FATE FATE THERAPEUTICS INC 45,936 0.0416
ARKK 27 Jul 2021 Buy FATE FATE THERAPEUTICS INC 96,037 0.0337
ARKK 26 Jul 2021 Buy FATE FATE THERAPEUTICS INC 85,505 0.0308
ARKK 23 Jul 2021 Buy FATE FATE THERAPEUTICS INC 74,121 0.0270
ARKK 22 Jul 2021 Buy FATE FATE THERAPEUTICS INC 82,301 0.0304
ARKK 21 Jul 2021 Buy FATE FATE THERAPEUTICS INC 38,816 0.0142
ARKK 20 Jul 2021 Buy FATE FATE THERAPEUTICS INC 36,661 0.0137
ARKK 19 Jul 2021 Buy FATE FATE THERAPEUTICS INC 92,286 0.0336
ARKK 16 Jul 2021 Buy FATE FATE THERAPEUTICS INC 57,875 0.0206
ARKG 15 Jul 2021 Buy FATE FATE THERAPEUTICS INC 152,712 0.1345
ARKG 14 Jul 2021 Buy FATE FATE THERAPEUTICS INC 70,126 0.0602
ARKK 8 Jul 2021 Buy FATE FATE THERAPEUTICS INC 32,305 0.0115
ARKK 7 Jul 2021 Buy FATE FATE THERAPEUTICS INC 535,305 0.1894
ARKK 11 May 2021 Buy FATE FATE THERAPEUTICS INC 64,210 0.0241
ARKG 10 May 2021 Buy FATE FATE THERAPEUTICS INC 52,093 0.0483
ARKK 10 May 2021 Buy FATE FATE THERAPEUTICS INC 204,170 0.0775
ARKG 7 May 2021 Buy FATE FATE THERAPEUTICS INC 47,898 0.0432
ARKG 6 May 2021 Buy FATE FATE THERAPEUTICS INC 224,009 0.1973
ARKK 12 Apr 2021 Buy FATE FATE THERAPEUTICS INC 139,699 0.0436
ARKK 6 Apr 2021 Buy FATE FATE THERAPEUTICS INC 102,269 0.0342
ARKK 5 Apr 2021 Buy FATE FATE THERAPEUTICS INC 31,423 0.0109
ARKK 31 Mar 2021 Buy FATE FATE THERAPEUTICS INC 2,660 0.0009
ARKK 30 Mar 2021 Buy FATE FATE THERAPEUTICS INC 35,468 0.0123
ARKK 29 Mar 2021 Buy FATE FATE THERAPEUTICS INC 129,997 0.0444
ARKK 25 Mar 2021 Buy FATE FATE THERAPEUTICS INC 306,976 0.1075
ARKK 24 Mar 2021 Buy FATE FATE THERAPEUTICS INC 136,815 0.0521
ARKK 23 Mar 2021 Buy FATE FATE THERAPEUTICS INC 31,614 0.0117
ARKK 19 Mar 2021 Buy FATE FATE THERAPEUTICS INC 13,068 0.0049
ARKK 18 Mar 2021 Buy FATE FATE THERAPEUTICS INC 84,421 0.0314
ARKK 17 Mar 2021 Buy FATE FATE THERAPEUTICS INC 18,860 0.0066
ARKK 8 Mar 2021 Buy FATE FATE THERAPEUTICS INC 93,230 0.0368
ARKK 5 Mar 2021 Buy FATE FATE THERAPEUTICS INC 163,146 0.0617
ARKK 4 Mar 2021 Buy FATE FATE THERAPEUTICS INC 229,307 0.0894
ARKK 3 Mar 2021 Buy FATE FATE THERAPEUTICS INC 148,508 0.0577
ARKK 23 Feb 2021 Buy FATE FATE THERAPEUTICS INC 154,781 0.0556
ARKK 22 Feb 2021 Buy FATE FATE THERAPEUTICS INC 34,505 0.0132
ARKK 18 Feb 2021 Buy FATE FATE THERAPEUTICS INC 34,007 0.0127
ARKK 17 Feb 2021 Buy FATE FATE THERAPEUTICS INC 79,517 0.0287
ARKK 16 Feb 2021 Buy FATE FATE THERAPEUTICS INC 26,283 0.0096
ARKK 12 Feb 2021 Buy FATE FATE THERAPEUTICS INC 34,300 0.0125
ARKK 11 Feb 2021 Buy FATE FATE THERAPEUTICS INC 35,519 0.0133
ARKK 10 Feb 2021 Buy FATE FATE THERAPEUTICS INC 11,980 0.0046
ARKK 4 Feb 2021 Buy FATE FATE THERAPEUTICS INC 56,095 0.0227
ARKK 3 Feb 2021 Buy FATE FATE THERAPEUTICS INC 98,059 0.0394
ARKK 2 Feb 2021 Buy FATE FATE THERAPEUTICS INC 5,878 0.0023
ARKK 1 Feb 2021 Buy FATE FATE THERAPEUTICS INC 154,509 0.0608
ARKK 29 Jan 2021 Buy FATE FATE THERAPEUTICS INC 95,867 0.0400
ARKK 28 Jan 2021 Buy FATE FATE THERAPEUTICS INC 1,515 0.0000
ARKK 27 Jan 2021 Buy FATE FATE THERAPEUTICS INC 160,000 0.0611
ARKG 17 Dec 2020 Sell FATE FATE THERAPEUTICS INC 128,652 0.1934
ARKG 7 Dec 2020 Sell FATE FATE THERAPEUTICS INC 174,345 0.2889
Latest Blogs
Cathie Wood's ARK Invest sells nearly 34,000 shares of Tesla

On Monday, a large number of shares of an exchange-traded fund (ETF) managed by ETF star Cathie Wood were sold. In particular, this fund sold nearly 34,000 shares of Tesla Inc. (NASDAQ: TSLA), despite the fact that the fund's price had increased by more than 1 percent on the day. It should be noted that the fund has experienced a significant decline over the past year.

 

The ARK Innovation ETF (NYSEARCA: ARKK) was responsible for the sale of 33,919 shares of Tesla. At Monday's closing price, the transaction would have been valued at approximately $34.2 million. Despite the fact that this represents a small portion of the total holdings, every little bit helps. In the last year, the fund has lost 17 percent of its value.

 

Cathie Wood's ARK Transparency ETF (CTRU) is preparing to make its debut on Wednesday, according to the company.

In preparation for Cathie Wood's launch of the ARK Transparency ETF, financial markets are bracing themselves (BATS: CTRU). CTRU is set to launch on Wednesday and will aim to provide investors with exposure to stocks that exhibit the highest levels of transparency, openness, communication, and trust in their operations.

ARK believes that greater transparency fosters greater consumer confidence while also providing investors with long-term growth potential. Because of this, CTRU is designed to track the price movements of the Transparency Index on a continuous basis. The cumulative returns of the S & P 500 and the Transparency Index from October 1, 2016, to September 30, 2021, are depicted in the chart below.

The new fund will have an expense ratio of 0.55 percent, which is lower than the current one. Furthermore, the ETF will have 100 holdings, with the top three holdings being Cloudflare (NYSE: NET), Bloom Energy (NYSE: BE), and Enphase Energy (NYSE: E) (NASDAQ: ENPH). The top holdings and weightings of CTRU are detailed in the fund's fact sheet.

CTRU will be the ninth exchange-traded fund (ETF) launched by ARK Invest and the third index-based ETF. The fund will trade alongside Wood's flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK), which has amassed over $16 billion in assets under management as of the end of September.

The market's reaction to CTRU's unveiling will be determined in due course. If you're interested in a comparison, Wood's most recent ETF launch, the actively managed ARK Space Exploration & Innovation ETF (BATS: ARKX), saw $295 million worth of value traded in its initial public offering on March 30, 2021.

Although her actively managed exchange-traded funds have performed well this year, Wood's newest fund addition will be launched at a time when the sector has been under fire.

 

The Ark of Cathie Wood Invest falls into a bear market as tech bets turn sour.

Ark Invest's flagship Trade-traded fund has seen its losses for the year soar to 26 cents for every dollar invested, as investors sell off the high-growth but typically unprofitable technology stocks that were responsible for the fund's meteoric rise.

Ark Innovation, owned by trader Cathie Wood, opened down four cents on Monday, following a 12.6 cent decrease the previous week, the company's lowest seven-day stretch since February. Since its February high, the ETF has lost more than 40 cents for every dollar invested.

Ark Innovation is a $21.4 billion actively managed exchange-traded fund that invests in corporations in the United States that are pursuing "disruptive innovation," particularly in areas such as DNA systems, automation, robotics, and electrical power storage, synthetic intelligence, and financial technology.

In the past year, some of Ark's most valuable investments have been hammered, including the real estate marketplace Zillow, the virtual health care organization Teladoc, Zoom — the video clip meeting platform that was just one of the big winners of the pandemic — and Roku, a television streaming company.

 

AJ Bell, the UK's second-largest shown spending platform, claimed that "there has been a waning of enthusiasm for higher-growth tech companies." Russ Mould, the company's financial commitment director, said that A large portion of Ark Innovations' holdings is losing money, which is not ideal in an environment when interest rates are expected to climb.

Although Tesla, Ark's lone most prominent position, has recently weakened, its broad 2021 decline would have been substantially worse had it not been for the company's strong performance in 2018. Tesla is up 38 percent this year despite recent weakness.

Ark Innovation, according to Mould, has faced "some inventory-certain concerns, which have exposed some expensive valuations," in addition to risky technology stocks falling out of favor with investors.

Read full article https://www.clearpublicist.com/cathie-woods-ark-invest-slumps-to-bear-market-as-tech-bets-bitter/.